Company Profiles

driven by the PitchBook Platform

Tolera Therapeutics

Description

Developer of immune modulation transplant therapies created to address unmet medical needs with safer, targeted solutions. The company's immune modulation transplant therapies target the human alpha-beta T-cell receptor that appears to render pathologic T-cells inert and through a unique signaling pathway that expands regulatory T-cells in a novel, non-depleting manner, enabling the lives of patients suffering from a broad spectrum of autoimmune and immune-meditated diseases to improve.

2007

Founded

OOB

Status

Out of Business

Latest Deal Type

$19M

Total Amount Raised

Description

Developer of immune modulation transplant therapies created to address unmet medical needs with safer, targeted solutions. The company's immune modulation transplant therapies target the human alpha-beta T-cell receptor that appears to render pathologic T-cells inert and through a unique signaling pathway that expands regulatory T-cells in a novel, non-depleting manner, enabling the lives of patients suffering from a broad spectrum of autoimmune and immune-meditated diseases to improve.

Website:

www.tolera.com

Ownership Status

Out of Business

Financing Status

Formerly VC-Backed

Primary Industry

Pharmaceuticals

Primary Office

P.O. Box 970 Portage, MI 49081United States +1 (269) 585-2100
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Tolera Therapeutics's full profile, request a free trial.

    Tolera Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Tolera Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Tolera Therapeutics Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Harry Ledebur Ph.DChief Executive Officer & Board Member
    Melissa VrbaProject Manager
    Harry Ledebur Ph.D Chief Executive Officer & Board Member
    Melissa Vrba Project Manager

    Tolera Therapeutics Board Members (1)

    NameRepresentingRoleSinceContact
    Info
    Harry Ledebur Ph.DTolera TherapeuticsChief Executive Officer & Board Member000 0000
    Harry Ledebur Ph.D Chief Executive Officer & Board Member Tolera Therapeutics
    Request full access to PitchBook